Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 7
2004 11
2005 14
2006 21
2007 7
2008 10
2009 21
2010 21
2011 16
2012 16
2013 12
2014 15
2015 15
2016 27
2017 13
2018 14
2019 21
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

265 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: marquet p. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.
Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
Yazdani S, Callemeyn J, Gazut S, Lerut E, de Loor H, Wevers M, Heylen L, Saison C, Koenig A, Thaunat O, Thorrez L, Kuypers D, Sprangers B, Noël LH, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M. Yazdani S, et al. Among authors: marquet p. Kidney Int. 2019 Jan;95(1):188-198. doi: 10.1016/j.kint.2018.08.027. Epub 2018 Nov 3. Kidney Int. 2019. PMID: 30396694 Free article.
Pharmacodynamic Monitoring of mTOR Inhibitors.
Millán O, Wieland E, Marquet P, Brunet M. Millán O, et al. Among authors: marquet p. Ther Drug Monit. 2019 Apr;41(2):160-167. doi: 10.1097/FTD.0000000000000616. Ther Drug Monit. 2019. PMID: 30883509 Review.
Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study.
Van Loon E, Gazut S, Yazdani S, Lerut E, de Loor H, Coemans M, Noël LH, Thorrez L, Van Lommel L, Schuit F, Sprangers B, Kuypers D, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M. Van Loon E, et al. Among authors: marquet p. EBioMedicine. 2019 Aug;46:463-472. doi: 10.1016/j.ebiom.2019.07.028. Epub 2019 Aug 1. EBioMedicine. 2019. PMID: 31378695 Free PMC article. Clinical Trial.
Adherence profiles in kidney transplant patients: Causes and consequences.
Villeneuve C, Rousseau A, Rerolle JP, Couzi L, Kamar N, Essig M, Etienne I, Westeel PF, Büchler M, Esposito L, Thierry A, Marquet P, Monchaud C. Villeneuve C, et al. Among authors: marquet p. Patient Educ Couns. 2020 Jan;103(1):189-198. doi: 10.1016/j.pec.2019.08.002. Epub 2019 Aug 7. Patient Educ Couns. 2020. PMID: 31447197
Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
Woillard JB, Debord J, Monchaud C, Saint-Marcoux F, Marquet P. Woillard JB, et al. Among authors: marquet p. Clin Pharmacokinet. 2017 Dec;56(12):1491-1498. doi: 10.1007/s40262-017-0533-5. Clin Pharmacokinet. 2017. PMID: 28389935 Free article. Clinical Trial.
Endogenous Metabolites-Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity.
Martinez D, Muhrez K, Woillard JB, Berthelot A, Gyan E, Choquet S, Andrès CR, Marquet P, Barin-Le Guellec C. Martinez D, et al. Among authors: marquet p. Clin Pharmacol Ther. 2018 Oct;104(4):687-698. doi: 10.1002/cpt.1008. Epub 2018 Jan 31. Clin Pharmacol Ther. 2018. PMID: 29285751 Clinical Trial.
Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside.
Fleurence J, Bahri M, Fougeray S, Faraj S, Vermeulen S, Pinault E, Geraldo F, Oliver L, Véziers J, Marquet P, Rabé M, Gratas C, Vallette F, Pecqueur C, Paris F, Birklé S. Fleurence J, et al. Among authors: marquet p. Int J Cancer. 2020 Jan 15;146(2):424-438. doi: 10.1002/ijc.32533. Epub 2019 Jul 13. Int J Cancer. 2020. PMID: 31241171
Image-Based Marker-Free Screening of GABAA Agonists, Antagonists, and Modulators.
Rappaz B, Jourdain P, Banfi D, Kuttler F, Marquet P, Turcatti G. Rappaz B, et al. Among authors: marquet p. SLAS Discov. 2020 Jun;25(5):458-470. doi: 10.1177/2472555219887142. Epub 2019 Nov 28. SLAS Discov. 2020. PMID: 31779505 Free PMC article.
Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach.
Nanga TM, Doan TTP, Marquet P, Musuamba FT. Nanga TM, et al. Among authors: marquet p. Br J Clin Pharmacol. 2019 Dec;85(12):2793-2823. doi: 10.1111/bcp.14110. Epub 2019 Dec 17. Br J Clin Pharmacol. 2019. PMID: 31471970
265 results
Jump to page